Use of cardiac resynchronization therapy in patients hospitalized with heart failure
- PMID: 18697821
- DOI: 10.1161/CIRCULATIONAHA.108.773838
Use of cardiac resynchronization therapy in patients hospitalized with heart failure
Abstract
Background: The frequency and characterization of patients receiving cardiac resynchronization therapy (CRT) are largely unknown since the publication of pivotal clinical trials and subsequent incorporation of CRT into the American College of Cardiology/American Heart Association guidelines for heart failure.
Methods and results: We analyzed 33,898 patients admitted from January 2005 through September 2007 to 228 hospitals participating in the American Heart Association's Get With the Guidelines-Heart Failure program. There were 4201 patients (12.4%) discharged alive with CRT, including 811 new implants. Patients discharged with CRT were older (median age, 75 versus 72 years) and had lower median left ventricular ejection fraction (30% versus 38%), more frequent ischemic cardiomyopathy (58% versus 45%), more history of atrial fibrillation (38% versus 27%), and higher rates of beta-blocker and aldosterone antagonist use (P<0.0001 for all) than those without CRT. We found that 4.8% of patients with left ventricular ejection fraction <or=35% were discharged with a new CRT implant, which varied greatly by hospital. Ten percent of patients discharged with a new CRT implant had a left ventricular ejection fraction >35%. Major factors associated with lower rates of new CRT placement were treatment in the northeast (odds ratio, 0.40; 95% confidence interval, 0.30 to 0.53), black race (odds ratio, 0.45; 95% confidence interval, 0.36 to 0.57), increasing left ventricular ejection fraction per 10% (odds ratio, 0.56; 95% confidence interval, 0.52 to 0.60), and increasing age per 10 years in those >70 years of age (odds ratio, 0.56; 95% confidence interval, 0.48 to 0.65).
Conclusions: Although CRT is a recent evidence-based therapy for heart failure, patterns of use differ significantly from clinical trials and published guidelines. Important variations also exist for CRT therapy based on race, geographic region, comorbidities, and age and need to be addressed through further study and/or quality-of-care initiatives.
Comment in
-
Cardiac resynchronization therapy for heart failure: a hammer in search of nails.Circulation. 2008 Aug 26;118(9):901-3. doi: 10.1161/CIRCULATIONAHA.108.800722. Circulation. 2008. PMID: 18725501 No abstract available.
Similar articles
-
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure.JAMA. 2007 Oct 3;298(13):1525-32. doi: 10.1001/jama.298.13.1525. JAMA. 2007. PMID: 17911497
-
Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31. Circ Heart Fail. 2014. PMID: 24178311
-
Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007316. doi: 10.1161/CIRCEP.119.007316. Epub 2019 Jun 20. Circ Arrhythm Electrophysiol. 2019. PMID: 31216884 Free PMC article.
-
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy.JACC Heart Fail. 2017 May;5(5):388-392. doi: 10.1016/j.jchf.2017.02.018. JACC Heart Fail. 2017. PMID: 28449799 Review.
-
Cardiac resynchronization therapy in heart failure patients: an update.Cardiol J. 2009;16(3):197-209. Cardiol J. 2009. PMID: 19437393 Review.
Cited by
-
Association Between the Affordable Care Act Medicaid Expansion and Receipt of Cardiac Resynchronization Therapy by Race and Ethnicity.J Am Heart Assoc. 2022 Oct 4;11(19):e026766. doi: 10.1161/JAHA.122.026766. Epub 2022 Sep 21. J Am Heart Assoc. 2022. PMID: 36129039 Free PMC article.
-
Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion.Cureus. 2021 Sep 21;13(9):e18157. doi: 10.7759/cureus.18157. eCollection 2021 Sep. Cureus. 2021. PMID: 34692351 Free PMC article.
-
Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction.Curr Heart Fail Rep. 2021 Apr;18(2):41-51. doi: 10.1007/s11897-021-00502-5. Epub 2021 Mar 5. Curr Heart Fail Rep. 2021. PMID: 33666856 Free PMC article. Review.
-
Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients.Yonsei Med J. 2020 Nov;61(11):942-950. doi: 10.3349/ymj.2020.61.11.942. Yonsei Med J. 2020. PMID: 33107237 Free PMC article.
-
Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK.Appl Health Econ Health Policy. 2021 Mar;19(2):243-252. doi: 10.1007/s40258-020-00610-8. Epub 2020 Sep 24. Appl Health Econ Health Policy. 2021. PMID: 32970307 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
